It is a pleasure to invite you to visit our stand during Pharmapack - Pharma's dedicated packaging & drug delivery event (1 & 2 February 2017) at Paris expo Porte de Versailles - Hall 4, Stand A49 in Paris. The subject of our exhibition is "Ensuring safety during the process of designing and printing of pharmaceutical packaging, thanks to using modern software solutions Proof Suite by gradient".
Apart from artworkPlus - the first system to automatically create layouts for packaging in the pharmaceutical industry we are going to present the new version of PixelProof workflow- an intelligent and modern system which checks packaging for any possible differences against an approved reference in a matter of seconds.
On the second day of the fair 02.02.2017 at 2.40pm Frank Gilsebach is going to hold LearningLab: "Increase of quality and security of pharmaceutical packaging material"
- Artwork Life Cycle Management
- Errors on pharmaceutical packaging causes product recalls
- Increase of security of artwork generation
- Automatization of artwork generation and proofing
- Innovative solutions for pharmaceutical packaging quality control
According to statistics, drugs are still withdrawn from the market due to errors on the printed packaging material. Despite the tedious and accurate control, these errors can occur in the various stages of the process. The proofing and artwork generation software suite from gradient covers the whole Life Cycle of pharmaceutical artworks like folding boxes, labels, leaflets, booklets, tubes and aluminum foils. The software solutions artworkPlus from gradient improves the release of error free artworks consistently with less effort. The compliance and branding consistency is a key issue of the software suite. It improves the compliance of the artworks to internal and regulatory agencies and stands for a time and cost saving solution with error free compliant artworks.
The product Pixel Proof workflow is an easy to use proofing system for visual version control and compare the printed material against the approved artwork.